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Chronic obstructive pulmonary disease (COPD) is one of the most common lung
diseases worldwide, and is characterized by airflow obstruction that is not fully reversible
with treatment. Even though airflow obstruction is caused by airway smooth muscle
contraction, the extent of airway narrowing depends on a range of other structural and
functional determinants that impact on active and passive tissue mechanics. Cells and
extracellular matrix in the airway and parenchymal compartments respond both passively
and actively to the mechanical stimulation induced by smooth muscle contraction.
In this review, we summarize the factors that regulate airway narrowing and provide
insight into the relative contributions of different constituents of the extracellular matrix
and their biomechanical impact on airway obstruction. We then review the changes in
extracellular matrix composition in the airway and parenchymal compartments at different
stages of COPD, and finally discuss how these changes impact airway narrowing and
the development of airway hyperresponsiveness. Finally, we position these data in the
context of therapeutic research focused on defective tissue repair. As a conclusion,
we propose that future works should primarily target mild or early COPD, prior to the
widespread structural changes in the alveolar compartment that are more characteristic
of severe COPD.
Keywords: COPD, extracellular matrix proteins, airway obstruction, mechanics, collagen, elastin, proteoglycans,
emphysema
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is one of the most common lung diseases
worldwide, and is a consequence of (second-hand) exposure to tobacco smoke and/or
environmental pollutants. In 2012 it caused 6% of all deaths (World Health Organization, 2012)
and the burden of disease is increasing rapidly; currently affecting over 200 million people. The
WHO estimates that COPD will become the third leading cause of death in westernized countries
by 2020. COPD is characterized by a progressive loss of lung function with airflow obstruction that
is not fully reversible with bronchodilators (Rabe et al., 2007). Airflow obstruction is determined
as a reduction in the ratio of forced expiratory volume in 1 s (FEV1) over forced vital capacity
(FVC). FEV1 represents the volume of air an individual can expire with force within 1 s following
a deep inspiration, whereas FVC represents the total volume of air an individual can expire with
force following a deep inspiration. An FEV1/FVC ratio lower than 70% is considered a hallmark of
COPD, progresses with time, and is the principal determinant of disease severity in the GOLD I-IV
classification criteria (Rabe et al., 2007).
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Airflow obstruction in COPD is caused by a combination
of factors, including pulmonary inflammation associated with
bronchitis and mucus hypersecretion, small airways remodeling
and lung emphysema in varying combinations and severities
(Postma and Timens, 2006). Unfortunately, no current drug
treatments modify the course of the disease. Although chronic
inflammation of the peripheral airways and lung parenchyma
contributes to progressive obstruction of the airways, anti-
inflammatory glucocorticosteroids are largely ineffective in
inhibiting lung function decline (Barnes, 2013). Bronchodilators
are the mainstay of COPD treatment, of which long-acting
β2 agonists, long-acting anticholinergics and combinations
hereof have become the standard of care (Meurs et al., 2013).
Both classes of drugs act primarily on the airway smooth
muscle, reducing bronchoconstriction and therefore airflow
obstruction in a clinically meaningful way. Their effectiveness
is however also restricted, as even the most recently introduced
combination therapies of long-acting β2 agonists and long-acting
anticholinergics produce an improvement in FEV1 in the range of
∼150–200mL (Vogelmeier et al., 2013; Buhl et al., 2015), which
is clearly clinically significant, but represents an improvement
in the FEV1/FVC ratio of around 5 percentage points only.
Clearly, airway smooth muscle contraction is an important, but
not the main contributor to lung function decline in patients
with severe COPD. In this review, we summarize the factors that
regulate airway narrowing and provide insight into the relative
contributions of different constituents of the extracellular matrix
and their biomechanical impact on airway obstruction. We then
review the changes in extracellular matrix composition in the
airway and parenchymal compartments at different stages of
COPD, and finally discuss on how these changes impact airway
narrowing and the development of airway hyperresponsiveness.
Finally, we position these data in the context of therapeutic
research focused on defective tissue repair. As a conclusion, we
propose that future works should primarily target mild or early
COPD, prior to the widespread structural changes in the alveolar
compartment that are more characteristic of severe COPD.
Airway Mechanics in Different Structural
Compartments
Even though bronchoconstriction is triggered by airway smooth
muscle contraction, the extent of airway narrowing depends on a
range of other structural and functional determinants that impact
on active and passive tissue mechanics (Suki and Bates, 2008,
2011; Lauzon et al., 2012). The mechanical events occurring in
the lung are (i) the cyclic breathing imposed by the diaphragm on
the whole lung, (ii) the bronchoconstriction initiated by the active
contraction of the airway smooth muscle (ASM) and (iii) the
resulting stretching of the extracellular matrix (ECM) and of the
other cells that surround the airways (Politi et al., 2010; Lauzon
et al., 2012). These cells and ECM will respond both passively
and actively to the mechanical stimulation induced through their
intrinsic mechanical properties and via mechanotransduction
pathways (An et al., 2007). Therefore, a proper understanding
of lung mechanics in COPD needs to consider the role of the
cells and their ECM in the different structural compartments of
the lung, as well as their interplay (Suki and Bates, 2008, 2011;
Lauzon et al., 2012). Diverse experimental models have been
developed to address this topic at different scales (Wright et al.,
2013).
Extracellular Matrix Mechanics
The ECM is defined as a protein network mainly composed of
compliant elastin, stiff collagen and proteoglycans, all secreted
and organized by the cells embedded within this matrix (Dekkers
et al., 2009; Humphrey et al., 2014). It is a non-linear elastic
material that becomes stiffer when stretched (Storm et al., 2005;
Erk et al., 2010; Hiorns et al., 2014), but it is also a viscoelastic
material that relaxes or creeps under constant deformation or
load respectively (Faffe and Zin, 2009). These passive responses
are highly heterogeneous since they mainly depend on the
structural and mechanical properties of the collagenous network
(Shayegan and Forde, 2013), which in turn depends on the
presence of proteoglycans such as decorin (Pins et al., 1997).
In the lungs, the ECM in the close vicinity of the ASM cells is
dense and structurally different from the ECM that constitutes
the alveolar tissue outside the airway, i.e., the parenchyma
(Stamenovic et al., 2004).
The Airway Compartment
The airway compartment consists of the airway epithelium, the
reticular basement membrane, the subepithelial region, the ASM
layer and an adventitial region, which in larger airways contains
cartilage. The ASM cells can generate forces in response to
biochemical stimuli. The amount of force generated by each cell
is essentially determined by the amount of actomyosin fibers in
its cytoskeleton. This force is transmitted to the surroundings
through an actin network and adhesion complexes, which densify
and mature upon mechanical stimulation (Brenner, 1991; Gunst
and Zhang, 2008). The ability for the ASM cells to contract and
relax has been widely studied using in vitro cell cultures. Single
ASM cells plated on soft gels and stimulated with contractile
agonists exert tractions up to 200Pa (force normalized by the area
of application) on their substrate (Tolic-Norrelykke et al., 2002).
Such traction force microscopy (TFM) studies also show that the
forces applied by a cell on its surroundings are not isotropic (not
the same in every directions).
As far as mechanics is concerned, it is not only important
to focus on the ASM contractile cells that generate the driving
forces of bronchoconstriction, but it is also critical to characterize
the structural components on which these cells adhere, and that
withstand and transmit the forces across the lungs (An et al.,
2007; Khan et al., 2007, 2010). Because the ASM cells are aligned
around the airway with only a small angle deviating from the
transversal plane (Lei et al., 1997), their contraction results in a
circumferential force (Figure 1A). The orientation of the ASM
cells in the airway wall therefore determines the magnitude
of the resulting force applied during contraction and thus the
deformation of the airway as a whole (Bates and Martin, 1990;
Lei et al., 1997). This contraction leads to a shortening of the
perimeter (1P = 2pi.1r) or narrowing of the airway (1r), also
called bronchoconstriction (Bates and Martin, 1990; Figure 1A).
In a healthy lung, deep inspirations help the same cells to relax
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FIGURE 1 | The biomechanics from bronchoconstriction to COPD. (A) The contractile airway smooth muscle (ASM) is embedded in an alveolar tissue called
parenchyma. When they contract in reaction to external stimuli, the ASM cells aligned along the perimeter of the airway apply a radial force on the parenchyma, which
is deformed. In healthy lungs, the resulting airway narrowing is transient and fully reversible. (B) In case of COPD, chronic inflammation leads to chronic airway
hyperresponsiveness (AHR). Airway narrowing is more profound than in healthy lungs so that the ASM gets thicker by cell hypertrophy and ECM remodeling, which
prevents full reversibility of airway narrowing. The resulting sustained load expands the remodeling processes to the parenchyma, which mechanical properties are
affected up to disruption of the alveolar walls. Emphysema is particularly characteristic of severe COPD.
so that the airway dilates to recover its initial diameter after a few
breathing cycles (Lavoie et al., 2012; West et al., 2012).
The Parenchymal Compartment
The parenchymal compartment defines the alveolar tissue made
of interstitial cells and a large proportion of ECM, and which
surrounds the airways. The parenchymal tissue has a major
impact on airway mechanics due to its role in the tethering
of forces via the parenchymal attachments that in the end link
chest movements during inspiration to airway opening (Suki and
Bates, 2008, 2011; Lauzon et al., 2012). Parenchymal tethering
imposes an additional dynamic load on the airway smooth
muscle, which impacts on airway narrowing and supports
the relaxant effect of a deep inspiration (An et al., 2007).
The importance of the parenchymal lung tissue for airway
mechanics was recently demonstrated in a lung slice model of
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small airway narrowing following digestion of elastin and/or
collagen fibers (Khan et al., 2007, 2010). This shows that the
extracellular matrix has a key role in connecting the parenchymal
compartment to the airway compartment, and in affecting airway
mechanics.
Interplay Between the Airway and
Parenchymal Compartment: Role of the
ECM
ASM contraction imposes a deformation of the parenchyma
by a distance of 1r along the radial direction (Figure 1A).
The forces involved in this deformation propagate through the
parenchyma, which mechanical response is mainly controlled by
the parenchymal ECM (Yuan et al., 1997; Cavalcante et al., 2005).
The local stiffness of the parenchymal segments and junctions
measured in decellularized lung tissues was shown to be rather
homogeneous but to increase close along the pleura (Luque et al.,
2013). The heterogeneities of the mechanical cues sensed by the
cells are thus mainly attributed to the heterogeneity of the local
geometries and architectures of the alveolar walls.
Moreover, intimate biomechanical interplays exist between
ASM cells and ECM (Suki and Bates, 2008; Zhang and Gunst,
2008; Dekkers et al., 2009). Indeed, the ECM on which cells
adhere is a dynamic material with mechanical properties that
are passively and actively adapted to the forces it undergoes. The
process of mechanotransduction leads the mechanical properties
of the microenvironment to control a lot of cellular cues
such as differentiation (Huang et al., 2012), proliferation, the
cellular compliance to deformation/relaxation (Stamenovic et al.,
2004), but also ECM maintenance (Humphrey et al., 2014).
The collagen, elastin and proteoglycans contents as well as the
organization of the ECM are therefore continuously actively
adjusted by the cells so as to match the requirements of the
mechanical environment and ensure tissue integrity.
Because the ECM plays key roles in force transmission
throughout the tissue, changes in ECM composition in COPD
may impact on the association between ASM cell shortening on
the one hand and airflow obstruction defined as a reduction in
the FEV1/FVC ratio on the other.
EXTRACELLULAR MATRIX CHANGES IN
COPD AIRWAYS AND LUNG
PARENCHYMA
In view of the key role of the ECM in determining airway
narrowing, it is of importance to consider the changes in ECM
expression in COPD. The altered expression of ECM proteins is
one of the pathological hallmarks characterizing the progression
of COPD and contributes to remodeling the airways and the
parenchyma. Of particular interest is the relationship between
COPD severity and ECM protein expression as in severe COPD,
parenchymal tissue damage (emphysema) is more profound,
whereas in mild to moderate COPD, emphysema is milder on
average (Wang et al., 2015). It is therefore important to make
an inventory of the changes in ECM composition in mild to
moderate COPD and to question whether these changes in tissue
integrity are sufficient to induce changes in airway narrowing,
even in patients without obvious emphysema. This discussion is
also relevant to early COPD, although little data is available as to
the ECM expression characteristics in early COPD. Although not
a main focus in this review, this discussion may even be relevant
to healthy smokers as a subpopulation of healthy smokers of
around 27% has emphysema revealed by computed tomography
in comparison to 1.1% of healthy non-smokers (Hoffman et al.,
2014; Smith et al., 2014)
Various studies have shown altered expressions of major
ECM components such as elastin, collagen and proteoglycans
in COPD, compared to healthy smokers or healthy controls
(Table 1). Those studies also indicate differences in the levels
of ECM protein dependent on the COPD stage, showing that
remodeling is already present in mild or moderate COPD,
but progresses to more significant pathology in severe disease
(Hogg and Timens, 2009). Some proteins exhibit specific changes
in expression dependent on location, e.g., small airways or
parenchymal tissue. A summary of the main changes in ECM
protein expression in COPD according to severity and location
is provided in Table 1.
Elastic Fibers
An important finding is the decrease in the protein expression
of elastin, the volume fraction of which is reduced in both
airways and alveoli of patients with COPD in comparison to
controls (Black et al., 2008). This reduction appears similar in
both mild to moderate and severe COPD airways (Eurlings et al.,
2014). The expression of elastin in the parenchyma was also
found reduced in patients with mild to moderate and severe
COPD in that study (Eurlings et al., 2014) and by others in
mild to moderate COPD (Merrilees et al., 2008). However, some
have reported increased expression of elastin in the remaining
alveolar walls in patients with severe COPD (Vlahovic et al.,
1999). Furthermore, in patients with mild to moderate COPD,
Annoni et al. report no changes in elastic fiber content in
comparison to healthy subjects, whereas elastic fiber content
in these patients is reduced in comparison to healthy smokers
(Annoni et al., 2012). Interestingly, Deslee et al. showed that
the elastin fibers in the alveolar walls of patients with severe
COPD are considerably less densely packed, unraveled and loose
in comparison to healthy subjects (Deslee et al., 2009). These
changes occur in spite of increased elastin mRNA expression
in patients with severe COPD, indicating inadequate attempts
to activate a repair process in these patients. Thus, whereas
the available reports are disconcordant in terms of total elastin
expression in the parenchyma in patients with COPD, possibly
the elastin fibers present are less well organized and looser in
comparison to healthy controls, contributing to the progressive
loss of elastic recoil in small airways and parenchyma in patients
with COPD. These changes in elastin are relevant to both mild to
moderate and severe COPD, although clearly more profound in
severe COPD.
Proteoglycans
A similar decline in protein levels is found for the proteoglycans
biglycan and decorin in the peribronchial region and
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TABLE 1 | Extracellular matrix changes in airways and parenchyma of patients with COPD.
ECM protein Mild/moderate COPD Small airways Mild/moderate COPD Parenchyma Severe COPD Small airways Severe COPD Parenchyma
References References References References
Elastin ↓ Eurlings et al., 2014 ↓
↓
↔
Eurlings et al., 2014
Merrilees et al., 2008
Annoni et al., 2012
↓ Eurlings et al., 2014 ↓
↑
↑
Eurlings et al., 2014
Vlahovic et al., 1999
Deslee et al., 2009
Biglycan ↔ Annoni et al., 2012 ↔ Annoni et al., 2012 ↓ van Straaten et al., 1999 ↓ van Straaten et al., 1999
Decorin ↔ Annoni et al., 2012 ↔ Annoni et al., 2012 ↓
↓
Zandvoort et al., 2006
van Straaten et al., 1999
↓
↓
Zandvoort et al., 2006
van Straaten et al., 1999
Versican ↔ Annoni et al., 2012 ↑
↓
Merrilees et al., 2008
Annoni et al., 2012
↑ Hallgren et al., 2010 ↑ Hallgren et al., 2010
Total Collagen ↑ Eurlings et al., 2014 ↑ Eurlings et al., 2014 ↑ Eurlings et al., 2014 ↑ Eurlings et al., 2014
Collagen I ↓
↑
↑
Annoni et al., 2012
Harju et al., 2010
Kranenburg et al., 2006
↓ Annoni et al., 2012 ↓ Harju et al., 2010
Collagen III ↓
↔
Harju et al., 2010
Annoni et al., 2012
↔ Annoni et al., 2012 ↓ Harju et al., 2010
Collagen IV ↔ Annoni et al., 2012 ↔ Annoni et al., 2012
Tenascin ↑
↑
↑
Annoni et al., 2012
Lofdahl et al., 2011
Liesker et al., 2009
↔ Annoni et al., 2012
Fibronectin ↑ Annoni et al., 2012 ↔ Annoni et al., 2012 ↓ Gosselink et al., 2010
Hyaluronan ↑
↑
Eurlings et al., 2014
Dentener et al., 2005
↑ Eurlings et al., 2014 ↑ Eurlings et al., 2014 ↑ Eurlings et al., 2014
Laminin ↔
↔
↑
van Straaten et al., 1999
Liesker et al., 2009
Kranenburg et al., 2006
parenchyma of patients with severe COPD (van Straaten
et al., 1999; Zandvoort et al., 2006). The loss of decorin
expression in the parenchyma correlated positively to
COPD severity and paralleled a decrease in abundance
of TGF-β1 in the patients with severe COPD (Zandvoort
et al., 2006). A trend for reduced expression of biglycan
in parenchyma of patients with mild to moderate COPD
compared to non-smokers and a significant reduction in
decorin expression in parenchyma of patients with COPD
in comparison with non-smokers has also been reported
(Annoni et al., 2012). This suggests that alterations in the
abundance of these proteoglycans are more pronounced in
severe COPD.
In contrast to biglycan and decorin, the proteoglycan versican
was found increased in mild to moderate COPD, inversely
correlating to the elastic fiber content (Merrilees et al., 2008).
This fits with findings showing increased versican production by
fibroblasts obtained from COPD patients in comparison to those
obtained from non-smoking controls (Hallgren et al., 2010). High
levels of versican may contribute to the loss of elastic fibers
during progression of COPD as versican inhibits synthesis and
regeneration of these fibers (Merrilees et al., 2008). Nonetheless
Annoni et al. (2012) found no changes in versican content in
the airway compartment and even somewhat reduced versican
levels in mild to moderate COPD patients in comparison to non-
smoking controls. The reason for this apparent discrepancy is not
clear, but can be related to the different methods of analyses used
in both studies.
Collagens
For collagen the studies are inconsistent. Increased total collagen
expression in the airway and parenchymal compartment of both
mild to moderate and severe COPD has been reported (Eurlings
et al., 2014); however, the precise contribution of individual
collagen subtypes to this change is unclear. The most abundant
collagens in airway ECM are fibrillary collagen type I and III
and non-fibrillary collagen type IV. In several studies, both
increased and reduced collagen I levels in the small airways
and parenchyma, both in mild to moderate and in severe
COPD have been reported (Kranenburg et al., 2006; Annoni
et al., 2012; Eurlings et al., 2014). According to Annoni et al.
(2012), the levels of collagen type IV in patients with moderate
COPD are comparable to controls. The same was concluded for
collagen III, whereas, Harju et al. (2010) report an upregulated
expression of the precursor for collagen III in patients with
mild to moderate COPD. With the results being controversial,
no general conclusion for the expression of collagens in COPD
can be drawn. The discrepancy between the studies may be
explained by disconcordant behavior of collagen expression in
COPD phenotypes, but insufficient data is available to conclude
on this aspect. However, given the reduced expression of collagen
cross-linking molecules such as decorin and biglycan in severe
COPD, the strength of the collagen fibrils may be reduced in
COPD (Corsi et al., 2002; Postma and Timens, 2006). Indeed,
recent studies using second harmonic generation two-photon
microscopy revealed that in COPD the ratio of the number of
mature, organized collagen fibrils over the number of immature,
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disorganized collagen fibrils is lower in COPD than in healthy
controls (Tjin et al., 2014).
Others
For the glycoproteins tenascin and fibronectin increased levels
were found in the airways of mild to moderate COPD patients,
inversely correlating with lung function of these patients (Liesker
et al., 2009; Lofdahl et al., 2011; Annoni et al., 2012). No change
in expression was found in the parenchyma (Annoni et al., 2012),
although fibronectin gene expression may be reduced in severe
COPD (Gosselink et al., 2010). The levels of the polysaccharide
hyaluronan in the ECM are upregulated in patients with COPD,
and this is considered to be related to local inflammation in the
lung airways (Dentener et al., 2005; Eurlings et al., 2014). No
major changes in the expression of laminins have been reported
(van Straaten et al., 1999; Liesker et al., 2009), although increased
expression of laminin β2 has been reported in airway smooth
muscle of patients with mild to moderate COPD (Kranenburg
et al., 2006).
Summary of ECM Changes in COPD
In summary, the extracellular matrix in the airway and
parenchymal compartments of patients with COPD is changed
in comparison to healthy controls. The most notable and
consistently reported changes, relevant to the discussion on
airway function, are reductions in the expression or functional
organization of elastic fibers and small molecule proteoglycans
such as biglycan and decorin in the airways and parenchyma.
Some of these changes (notably the changes in elastin) are already
visible in mild to moderate COPD and progress toward severe
COPD. In addition, fibrosis of the small airways with increased
expression of tenascin-C, fibronectin and possibly collagens in
patients with mild to moderate COPD can be observed. For
severe COPD, these results are more conflicting.
THE TIME COURSE OF BIOMECHANICAL
CHANGES IN COPD
In order to properly capture the time course of the biomechanical
phenomena occurring in COPD progression, it is necessary
to recognize that different time scales are involved in lung
mechanics. The biological reaction induced by exposure of ASM
cells takes from dozens of seconds to few minutes before an
active contraction of the ASM is triggered (Aaron et al., 2012).
Then, the elastic response of the extracellular material subjected
to the resulting mechanical load occurs instantaneously whereas
the viscous response takes an additional dozens of seconds
to minutes. Such contractile events occur in addition to the
continuous tidal strain imposed by the 12–20 breaths per minute,
which is essential for the glassy ASM cells to keep their fluid-like
behavior (Krishnan et al., 2008).
Bronchoconstriction induces a temporary stiffening of the
smooth muscle and thus the reduction of the tidal stretch of the
airway compartment, which temporarily lead (i) the ASM cells to
stiffen by reinforcement of their cytoskeleton (An et al., 2006), (ii)
the parenchymal ECM to respond (visco)elastically and undergo
strain stiffening (Faffe and Zin, 2009) and (iii) the parenchymal
cells to temporarily reinforce their actin cytoskeleton for adapting
to their new mechanical environment (Trepat et al., 2007).
Those phenomena occur within minutes after the contraction.
When the ASM relaxes, the cells are properly stretched by the
tidal breath again, which helps with recovering their fluid-like
behavior (Krishnan et al., 2008). As a consequence, the ECM
recovers (visco)elastically its initial mechanical state, also within
minutes after dilation of the healthy airway.
In a healthy lung, the mechanical effects on the cells and
the ECM are thus expected to be limited in time, so that
cells don’t require long term mechanical adaptation through
ECM remodeling. In contrast, bronchoconstriction is usually
more frequent for a longer time in a lung subjected to chronic
inflammatory reactions induced by chronic smoke or allergens
exposure (Meurs et al., 2008). This increased responsiveness
to constricting stimuli is called airway hyper responsiveness
(AHR). It is one of the hallmarks of asthma, but is also found
in patients with COPD (van den Berge et al., 2012). AHR
enhances the frequency and duration of the mechanical loads
applied to the cells, which then cope with these changes by
remodeling the ECM in their close vicinity (Gosens and Grainge,
2015). In contrast to passive mechanical responses of the lung
tissue that are almost immediate (seconds to minutes), active
mechanical responses at the tissue scale like remodeling processes
are slower (days to weeks) since they involve ECM degradation
and formation.
Chronologic Development of COPD
The inflammatory process at the onset of the disease recruits
immune cells such as macrophages that secrete various enzymes
among which the metallo-elastase (MMP-12) (Lagente et al.,
2009). The resulting early degradation of the elastic fibers is
potentially the first change of the ECM (Merrilees et al., 2008;
Eurlings et al., 2014) and the recoil property of the airway is
thus the first mechanical feature to be affected in the course of
COPD. Additionally, hyaluronan polysaccharides attract water,
which gives the ECM additional resistance to compression
(Cavalcante et al., 2005). These changes in the mechanics of
airway ECM prevent the full recovery of the original airway
caliber when the ASM relaxes after bronchoconstriction (Chung,
2005). Also, elastin fragments resulting from the MMP-12 action
further promote the recruitment of macrophages and a first
short range vicious circle of ECM remodeling settles in the
airway compartment (Lagente et al., 2009). This early sequence
of events would already explain the progressive narrowing of
the airways and thus the slow degradation of lung function
characteristic of the first stage of COPD without obvious
emphysema.
These mild airflow limitations being almost imperceptible and
therefore usually not treated, both the airway and parenchymal
compartments remain mechanically stressed for periods of
time sufficient to trigger mechanotransduction pathways in
the lung tissue. Indeed, if the smooth muscle has not fully
recovered its basal tone, the airway cells are embedded in
a new mechanical environment, which they tend to remodel
so as to recover a mechanical equilibrium (Humphrey et al.,
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2014). For example, the long lasting compressive stresses
that remain in the airway compartment after a non-fully
reversible episode of bronchoconstriction (Brook et al., 2010)
would explain an abnormal reinforcement of the ECM by
deposition of fibronectin in the small airways in mild to
moderate COPD, but also the buckling of the collagen fibers
observed by second harmonics generation by Tjin et al. (2014).
The increase of tenascin, fibronectin, and possibly collagen
expressions in these airways is characteristic of fibrosis, which
also contributes to the stiffening of the overall airway wall
and thereby further impairs the ability for the embedded ASM
cells to relax in the presence of bronchodilators. Therefore, a
second vicious circle of ECM remodeling further characterizes
the development of the disease in the airway compartment (Suki
et al., 2013).
During mild to moderate COPD, mainly the recoil properties
of the parenchyma are affected with changes in elastin and
hyaluronan expressions (Table 1). Nevertheless, as the airway
compartment gets stiffer, an increasing part of the forces
generated by the ASM is transmitted to the parenchymal
compartment, which progressively gets and remains more and
more stretched (Figure 1B). The mechanical properties of the
parenchyma are mainly determined by those of the collagenous
network subjected to strain stiffening. Even though the results
on the evolution of collagen content are somehow conflicting
in the literature (Table 1), there is a clear reduction of decorin
and biglycan, which insure the formation and cross-linking of
collagen fibers. This change in the expression of proteoglycans
could be explained by the interstitial cells actively compensating
the passive strain stiffening of the collagen fibers by decreasing
their crosslinking to soften whole collagenous network. However,
these changes not only decrease the rigidity but also the strength
of alveolar tissue. When some fibers start to break under a
critical loads, part of the stress is released in deformation of
the surroundings and part is redistributed to the fibers close
by. The amount of interstitial cells in the parenchymal tissue is
not sufficient to insure the maintenance of the alveolar ECM
that is continuously degraded. Therefore, a third vicious circle
of ECM remodeling/degradation characterizes the propagation of
the disease in the parenchymal compartment (emphysema) (Suki
et al., 2013).
IMPLICATIONS FOR FUTURE RESEARCH
ON COPD
The present review gathers various biomechanical studies
performed from the molecular to the organ scale, focusing on
the airway and the parenchymal compartments of the lung, and
taking into account cellular and extracellular players. Through its
integrative point of view on airway mechanics, this article reveals
an original perspective on the progression of airway narrowing
in COPD. This review indeed suggests that altered ECM
compositionmay affect airwaymechanics in COPD, independent
of or in addition to parenchymal destruction. Changes in
airway wall stiffness, elastic fiber content and composition, and
collagen cross-linkingmolecules such as decorin and biglycan are
sufficient to explain changes in airway mechanics in COPD.
The implications of this discussion are significant for studies
focusing on airway narrowing and lung repair in COPD. If
changes in ECM expression resulting in altered airway wall
stiffness and looser parenchymal structure are sufficient to
explain at least a part of increased airway narrowing in those
mild to moderate COPD patients without obvious emphysema,
then it is maybe more prudent to target with drugs the patients in
this time specific window during the early progression of COPD.
Indeed, damaged tissue is difficult to repair whereas disorganized,
yet physically intact tissue may still have a reasonable chance. As
a consequence, future studies are clearly needed to estimate the
impact of various degrees of ECM damage on airway narrowing.
In addition, it would be recommended that investigations
focusing on mechanisms of tissue repair incorporate airway
mechanics as a read-out to measure the functional impact of the
regenerative strategy.
Among the multiple experimental models encountered in
the studies cited throughout this review, precision cut lung
slices (PCLS) harvested from animals or human donors appear
to be well suited to such questions at an intermediate scale
(Konigshoff et al., 2011; Sanderson, 2011). Indeed, lung slices
can be harvested from healthy or diseased specimen, are viable
in vitro for several days and provide a natural co-culture, which
preserves the native biochemical and mechanical interactions
between cells of different types and their ECM. This integrative
model of the airway system gives insights in the interplay
occurring between the different compartments of the tissue,
when contraction and relaxation are chemically induced either
at rest (Konigshoff et al., 2011; Ma et al., 2013) or under
oscillating stretch to account for the benefits of breathing (Lavoie
et al., 2012). Despite the loss of three dimensional structures
that may be important for the structural changes occurring
during bronchoconstriction, the two dimensional character of
the PCLS facilitates the use of many visualization techniques
necessary to achieve a reasonable characterization of these
changes. Direct comparison between image analysis results and
computational models enables the estimation of some properties
of the system, not accessible otherwise (Brook et al., 2010). Such
computational models supported by experimental evidences are
of high interest to simulate the mechanosensing feedback loop
between mechanical properties and remodeling in healthy and
pathological contexts such as COPD. PCLS constitute therefore a
very useful experimental model to explore the consequences of
extracellular damage on airway narrowing, but also to test the
efficiency of treatments on airway function and understand their
action on the airway system as a whole.
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